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SUMMARY
N-terminal acetylation is a major and vital protein
modification catalyzed by N-terminal acetyltrans-
ferases (NATs). NatF, or Na-acetyltransferase 60
(Naa60), was recently identified as a NAT in multicel-
lular eukaryotes. Here, we find that Naa60 differs
from all other known NATs by its Golgi localization.
A new membrane topology assay named PROMPT
and a selective membrane permeabilization assay
established that Naa60 faces the cytosolic side of
intracellular membranes. An Nt-acetylome analysis
of NAA60-knockdown cells revealed that Naa60, as
opposed to other NATs, specifically acetylates trans-
membraneproteins andhasapreference forN termini
facing the cytosol. Moreover, NAA60 knockdown
causes Golgi fragmentation, indicating an important
role in themaintenance of theGolgi’s structural integ-
rity. This work identifies a NAT associated with mem-
branous compartments and establishes N-terminal
acetylation as a common modification among trans-
membrane proteins, a thus-far poorly characterized
part of the N-terminal acetylome.
INTRODUCTION
N-terminal acetyltransferases (NATs) belong to a family of en-
zymes containing a Gcn5-related N-acetyltransferase (GNAT)
fold. The NATs transfer an acetyl group from acetyl coenzyme
A (Ac-CoA) to the a-amino group of substrate protein N termini.
NATs are distinguished from each other by their subunit com-
position (designated Na-acetyltransferases, or Naas), and the
type of N termini they acetylate—in particular the first two resi-
dues—are of importance (Starheim et al., 2012). A wide range
of functional effects of the N-terminal (Nt) acetyl group have
been shown for a selection of NAT-modified proteins (Arnesen,
2011). Although the overall biological function of this ubiquitous
and cotranslational process has been difficult to pinpoint,
several reports suggest its impact on protein subcellular locali-
zation (Behnia et al., 2007; Behnia et al., 2004; Murthi and Hop-
per, 2005; Setty et al., 2004), protein lifetime/degradation
(Hwang et al., 2010; Shemorry et al., 2013), and protein-protein
interactions (Monda et al., 2013; Scott et al., 2011).
NatF (Naa60) is the most recently identified member of the
NAT family and was shown to be conserved among multicellular
eukaryotes while absent from unicellular eukaryotes such as
yeast (Van Damme et al., 2011b). NatF contributes to an evolu-
tionary shift toward increased N-terminal acetylation (Nt-acety-
lation), as demonstrated by additional substrate Nt-acetylation
in yeast ectopically expressing hNaa60 (Van Damme et al.,
2011b). Thus, it seems that Naa60 is capable of operating
independently, and no additional subunits have been described
for NatF. N termini recognized by NatF include those starting
with Met-Lys as well as other Met-starting N termini, preferen-
tially those followed by a hydrophobic amino acid (Van Damme
et al., 2011b). Previously, these N termini were thought to
be acetylated by NatC (Naa30) (Polevoda et al., 1999; Starheim
et al., 2009) and NatE (Naa50) (Evjenth et al., 2009; Van Damme
et al., 2011a). As such, the addition of NatF to the NAT
family revealed some potential redundancy among these three
enzymes.
Depletion of NAA60 in Drosophila Dmel2 cells results in
abnormal chromosome segregation during anaphase (Van
Damme et al., 2011b), a phenotype similar to that of NAA50-
depleted cells (Hou et al., 2007; Pimenta-Marques et al., 2008;
Williams et al., 2003). A Drosophila genetic screen implied an
important physiological role for Naa60 related to neural func-
tioning, possibly linking Naa60 to infantile neuronal ceroid lipo-
fuscinosis (Buff et al., 2007). It has not been determined how
these cellular and physiological phenotypes may be manifested
through protein-substrate effects that may occur in the absence
of NatF-mediated Nt-acetylation.
The eukaryotic NATs NatA–E are all cytosolic and interact
with ribosomes either via an auxiliary subunit (Gautschi et al.,
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of the Golgi ribbon is also suggested to be linked to a G2/M cell-
cycle checkpoint (Rabouille and Kondylis, 2007). Thus, the Golgi
phenotype observed here in Naa60-depleted HeLa cells may be
linked to the chromosome-lagging phenotype described in
Naa60-depleted Drosophila cells, where Naa60 was suggested
to be important for normal chromosome segregation during
anaphase pr gression (Van Damme et al., 2011b).
In conclusion, this work characterizes Naa60 as the first re-
ported membrane-associated NAT. Naa60 specifically acety-
lates cytosolic N termini of transmembrane proteins and is
important for Golgi ribbon integrity. As we have also shown Nt-
acetylation to be a commonmodification amongmembrane pro-
teins, we propose that Naa60 is necessary for maintenance of
the Golgi ribbon through its Nt-acetylation of substrate protein(s)
hat is/ re involved in Golgi ribbon structural and/or functional
organization.
EXPERIMENTAL PROCEDURES
HeLa, HeLaS3, A-431, and 293 cells were transfected with Fugene 6 (Roche/
Promega), X-tremeGENE 9 (Roche), or Effectene (PROMPT validation experi-
ments) according to the manufacturer’s protocol. 0.25–0.5 mg DNA was used
per ml culture medium. Unless otherwise indicated, cells were used for down-
stream experiments 12–24 hr posttransfection. NAA60 knockdown was per-
formed by transfection using Dharmafect 1 (GE Dharmacon) or HiPerFect
(QIAGEN) according to the respectivemanufacturer’s protocols, with th addi-
tion of 5 nM pan-caspase inhibitor Z-VAD-FMK (renewed every 24 hr by
replacing half of the culture medium). Cells were harvested or fixed approxi-
mately 72 or 96 hr post-siRNA transfection. Further cell culture details andma-
terial specifications on siRNA and shRNA are provided in the Supplemental
Experimental Procedures.
For preparation of crude A-431 cell fractions, cells were harvested and dis-
solved in homogenization buffer (0.25M sucrose, 1mMEDTA, 20mMHEPES-
NaOH [pH 7.4]), after which nuclei were removed by sedimentation at 3,0003
g for 5 min and organelles and cytosol were separated by centrifugation at
17,000 3 g for 20 min. SILAC-labeled fractionated A-431 cells were used for
N-terminal COFRADIC analysis, as previously described (Staes et al., 2011;
Van Damme et al., 2009) and detailed in the Supplemental Experimental
Procedures.
Standard procedures were followed for immunocytochemistry, and the
buffers, antibodies, and incubation times are given in detail in the Supple-
mental Experimental Procedures. Fluorescent images in Figures 3B, 6A, and
6D were btained on a Leica TCS SP2 AOBS. Fluoresc nt images in Figures
6A and 6D were obtained on z stacks of 0.2- to 0.3-mm-thick optical sections
spanning the entire depth of Golgi complexes and are shown as maximum-in-
tensity projections, and insets are presented as projections of two or three
successive sections. All other fluorescent image were btained on a Leica
DMI6000 B wide field microscope. Further instrument details can be found
in the Supplemental Experimental Procedures. The acquired images were pro-
cessed using the Photoshop CS5 image software (Adobe Systems).
Detailed information on additional procedures, including bioinformatics
tools used and construction of plasmids, are available in the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.01.053.
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N-terminal COFRADIC analysis, as previously described (Staes et al., 2011;
Van Damme et al., 2009) and detailed in the Supplemental Experimental
Procedures.
Standard procedures were followed for immunocytochemistry, and the
buffers, antibodies, and incubation times are given in detail in the Supple-
mental Experimental Procedures. Fluorescent imag s in Figures 3B, 6A, and
6D were obtained on a Leica TCS SP2 AOBS. Fluorescent images in Figures
6A and 6D were obtained on z stacks of 0.2- to 0.3-mm-thick optical sections
spanning the entire depth of Golgi complexes and are shown as maximum-in-
tensity projections, and insets are presented as projections of two or three
successive sections. All other fluorescent images were obtained on a Leica
DMI6000 B wide field microscope. Further instrument details can be found
in the Supplemental Experimental Procedures. The acquired images were pro-
cessed using the Photoshop CS5 image software (Adobe Systems).
Detailed information n a diti al procedures, including bioinformatics
tools used and construction of plasmids, are available in the Supplemental
Experimental Procedures.
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of th Golgi ribbon is also suggested to be linked to a G2/M cell-
cycle ch ckpoint (Rabouille and Kon ylis, 2007). Thus, the Golgi
phenotype observed here in Naa60-depl ted HeLa cells may be
linked to the chromosome-lagging phenotype described in
Naa60-depleted Drosophila cells, where Naa60 was suggested
to be important for normal chromosome segregation during
anaphase progression (Van Damme et al., 2011b).
In conclusion, this work characterizes Naa60 as the first re-
ported membrane-associated NAT. Naa60 specifically acety-
lates cytosolic N termini of transmembrane proteins and is
important for Golgi ribbon integrity. As we have also shown Nt-
acetylation to be a commonmodification amongmembrane pro-
teins, we propose that Naa60 is necessary for maintenance of
the Golgi ribbon through its Nt-acetylation of substrate protein(s)
that is/are involved in Golgi ribbon structural and/or functional
organization.
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tools used and construction of plasmids, are available in the Supplemental
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2003; Starheim et al., 2012) or, as in the case of NatD (consisting
only of Naa40), directly (Hole et al., 2011; Polevoda et al., 2009).
Studies of substrate Nt-acetylation have primarily focused on
cytosolic and soluble proteins, and it has been shown that a
majority of soluble yeast (>50%) and human (>80%) proteins
are subjected to this modification (Arnesen et al., 2009). So far,
the possibility and biological significance of Nt-acetylation of
membrane proteins has been much less described, in part
because no organelle-associated NAT has been identified.
Here, we describe the newly identified Naa60 as the first
organellar NAT and establish its membranous association
with the Golgi complex. We aimed to characterize the topology
Figure 1. Naa60 Associates with Organelles
as Opposed to the Other Known Human
Na-Acetyltransferases and Co-distributes
with Markers of the Golgi Apparatus
(A) Subcellular localization of all known human
Naas. HeLa cells expressing C-terminally V5-tag-
ged Naa10, Naa11, Naa20, Naa30, Naa40, Naa50,
and Naa60 were subjected to immunocytochem-
istry. Only Naa60 showed localization to intracel-
lular membranous compartments other than the
nucleus.
(B) Naa60-V5 expressing HeLa cells were co-
immunostained with anti-V5 and anti-GM130.
Low-Naa60-V5-expressing cells are shown.
(C) HeLa cells were treated with brefeldin A (BFA)
and co-immunostained with anti-Naa603-77 and
antibodies toward the cis/medial-Golgi marker
Giantin. As for Giantin, the perinuclear Golgi signal
of Naa60 was lost after BFA treatment.
Scale bars, 10 mm. See also Figures S1 and S3A.
of its active site as well as the substrates
of Naa60-mediated Nt-acetylation. By
knocking down NAA60, we identified a
Golgi structural phenotype and identified
several organellar substrates, thus indi-
cating a necessity for Naa60-mediated
Nt-acetylation in the maintenance of the
Golgi architecture and enlightening a
thus-far poorly characterized part of the
Nt acetylome.
RESULTS
Naa60 Differs from the Other
Known Na-Acetyltransferases by
Its Golgi Localization
The subcellular distribution of all known
human catalytic Na-acetyltransferases
(Naas) was investigated in HeLa cells
expressing these proteins with a C-termi-
nal V5 tag. Naa60 distributed in a
typical organellar localization pattern,
as opposed to Naa10, Naa11, Naa20,
Naa30, Naa40, and Naa50, which all
showed cytoplasmic and nuclear locali-
zations (Figure 1A).
Co-localization analyses showed that Naa60-V5 co-distrib-
uted with the cis-Golgi marker GM130 (Figure 1B). The endoge-
nous Naa60 also co-distributed with the cis/medial-Golgi protein
Giantin (Figure 1C, upper). Additional evidence for Naa60’s Golgi
residency was shown by its sensitivity to the Golgi-disrupting
drug brefeldin A (Klausner et al., 1992), which disrupted the peri-
nuclear staining of Naa60 (Figure 1C, lower).
In addition to the Golgi structure, both overexpressed and
endogenous Naa60 were found in vesicles spread throughout
the cell. These vesicles weakly co-localized withmarkers for per-
oxisomes (PMP70), endosomes (EEA1), lysosomes (LAMP1),
and secretory vesicles (HSA, Secretogranin II). In addition,
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Figure!S1.!Additional!co3localization!studies!related!to!Figure!1.!
SUPPLEMENTAL DATA 
!
Supplemental Figure legends 
!
Figure!S1.!Additional!co3localization!studies!related!to!Figure!1.!Weak%to%absent%co,localizations%were%
observed%for%tagged%and%endogenous%Naa60%with%various%markers%for%the%secretory%and%endocytic%pathway.!
The!first%column%shows%either%endogenous%or%overexpressed%tagged%Naa60%as%indicated;%the%second%column%
shows%the%subcellular%markers;%and%the%third%column%shows%an%overlay%and%the%rightmost%column%a%zoomed,in%
area%marked%in%the%preceding.%Note%that%there%is%a%difference%the%localization%pattern%of%endogenous%Naa60%
(Naa60),%which%was%more%confined%to%the%Golgi,%and%overexpressed%tagged%Naa60%(Naa60,tGFP),%which%was%
more%widely%distributed%to%other%intracellular%organelles.%The%following%organelle%markers%were%used:%PMP70:%
peroxisomes;%EEA1:%early%endosomes;%LAMP1:%lysosomes;%HSA%(human%serum%albumin):%secretory%vesicles;%
SCG2%(secretogranin%II):%secretory%vesicles;%PDI:%ER.%Scale%bar:%10%µm.!
 
Figure!S2.!Minor!or!no!impact!on!Naa60!membrane!localization!for!the!additional!regions!shown!in!Figure!
2A.!HeLa%cells%expressing%the%indicated%constructs.%
(A)%N,terminal%truncation%(Naa6014,242,tGFP)%and%N,terminal%tagging%(eGFP,Naa60)%interfered%somewhat%with%
the%localization%pattern%of%Naa60.%Note%also%that,%expressing%N,terminally%tagged%Naa60%resulted%in%increased%
appearance%of%enlarged%misshaped%vacuoles.%
(B)%Deletion%of%aa%78,87%putative%loop%(Naa6078,87Δ,tGFP)%did%not%perturb%Naa60%membrane%localization.%
Mutation%(Naa60L220/221A,tGFP)%or%deletion%(Naa60216,221Δ,tGFP)%of%the%QAHSLL%putative%endo/lysosomal%
targeting%signal%did%not%have%any%detectable%effect%on%Naa60%membrane%localization.%
(C)%Naa60%Cys,Ser%mutations%did%not%disrupt%Naa60%membrane%localization.%Several%variants%of%single%and%
multiple%mutations%were%performed.%The%most%extensive%are%shown.%
(D)%2,bromo%palmitate%(2,BP),treatment%did%not%detach%Naa60%from%organelles%but%somewhat%affected%Naa60%
subcellular%distribution,%as%vesicles%appeared%typically%larger%as%well%as%less%abundant%in%the%cell%periphery.%Scale%
bar:%10%µm.%
%
Figure!S3.!COFRADIC3related!validations,!representative!MS!spectra,!in#vitro!peptide!acetylation,!and!
substrate!localization!analysis,!supporting!Table!1.!
(A)%Validation%of%the%subcellular%fractionation%procedure%to%generate%organelle,%and%cytosol,enriched%proteome%
fractions.%A,431%cells%were%subjected%to%crude%subcellular%fractionation%by%means%of%differential%centrifugation.%
Endogenous%Naa60%co,segregated%with%the%organelle%marker%LAMP1%(Pellet%(3×)),%whereas%Naa10%and%Naa30%
were%present%in%the%cytosolic%fraction%(Super%(1×)).%3x%refers%to%3%equivalents%of%lysate%input%to%improve%
immunodetection.%
(B)%Validation%of%samples%prepared%for%COFRADIC.%A,431%cells%grown%in%13C6
15N4%L,arginine,containing%medium%
were%treated%with%non,targeting%control%siRNA%(siCTRL,%,)%and%cells%grown%in%12C6%L,arginine,containing%medium%
overexpressed Naa60-tGFP was observed to co-distribute well
with the ER marker PDI (Figure S1).
Naa60 Localization Depends on a C-Terminal
Membrane-Integrating Region
To investigate whether Naa60 contains targeting signals respon-
sible for its distinct organellar localization, we identified specific
regions unique for Naa60 among the catalytic Naas. The cata-
lytic subunits Naa30 and Naa50 that have overlapping substrate
specificities with Naa60 are also phylogenetically most closely
related. Recently, the crystal structure of Naa50 was resolved,
thereby providing a compatible reference for Naa60 (Liszczak
et al., 2011). By using published alignments (Van Damme et al.,
2011b) and comparing those to the Naa50 structure (Liszczak
et al., 2011), we found three regions of potential interest (indi-
cated in blue in Figure 2A): (1) the first 13 amino acids (aa) in
the N terminus, potentially serving as an N-terminal targeting
sequence; (2) aa 78–87, an extended sequence located between
the region corresponding to b strands 3 and 4 in the Naa50 struc-
ture (Liszczak et al., 2011), predicted as an extended loop; and
(3) aa 180–242 at the C terminus, representing an extension
only present in Naa60. The latter also contains a predicted
putative di-leucine endo/lysosomal-targeting signal QAHSLL
(aa 216–221) (by Eukaryotic Linear Motif [ELM]), highlighted in
red in Figure 2A. Furthermore, the C-terminal region contained
two putative transmembrane domains (TMDs) in regions 193–
213 and 217–236 predicted with a low probability (by TMpred,
TopPred, PRODIV PRO, and MEMSAT3). We also found two pu-
tative S-palmitoylation sites on C207 and C222 (by CCS-Palm
3.0). Of note, other weak transmembrane predictions were
found for regions around 52–69 (by TMpred, TMHMM, PRO
DIVPRO, SCAMPI-msa, OCTOPUS, TOPCONS, and MEMSAT-
SVM) and 84–104 (by TMpred and TopPred), but these were
considered unlikely, since they comprise part of the predicted
GNAT domain and align to b strands 3 and 4 of Naa50 (Liszczak
et al., 2011) and Naa10 (Liszczak et al., 2013). Examining Naa50
with several TM databases revealed that these areas could be
misread as potential transmembrane regions, likely owing to
the fact that GNATs in general have several hydrophobic interac-
tions in these structural domains (Dyda et al., 2000).
Based on these predictions, we made truncation and
deletion mutants (Figure 2B) and investigated their subcellular
Figure 2. TheNaa60CTerminus Is Required
and Sufficient for Membrane Localization
and Integration
(A) The Naa60 protein sequence with predicted
motifs and domains indicated. Dark purple,
transmembrane domains (predicted with low
probability); blue underlined, regions unique for
Naa60 among the catalytic Naas (aa 1–13, 78–87,
and 180–242); red underlined, putative endo/
lysosomal targeting signal, QAHSLL (aa 216–221);
C207 and C222 were predicted as putative S-
palmitoylation sites by CCS-Palm 3.0. The primary
sequence constituting the GNAT-domain together
with the core of the Ac-CoA-binding motif Q/
RxxGxG/A is indicated above.
(B) Naa60 constructs used for localization studies.
Color-coding as in (A).
(C) HeLa cells were transfected with the indicated
constructs and fixed. The membrane localization
observed for the full-length Naa60 (Naa601–242)
was lost by deleting the last 58 amino acids
(Naa601–184). eGFP-Naa60182–242 showed a
localization pattern resembling that of full-length
C-terminally tagged Naa60 whereas a shorter
construct, eGFP-Naa60217–242 localized to the
cytosol and nucleus. Naa601–242 and Naa601–184
were expressed from plasmid without tag and
detected with anti Naa603–77. Scale bar, 10 mm.
See also Figure S2.
(D) HeLa cells expressing untagged Naa60 were
subjected to subcellular fractionation yielding an
organellar pellet (P1), which was dissolved in
either sucrose buffer (pH 7.4) or sodium carbonate
buffer (pH 11.5) prior to a second centrifugation
yielding two sets of P2s and S2s. Naa60 shared its
western blot profile with the non-extractable inte-
gral membrane proteins Calnexin and RCAS1, as
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determined by PROMPT. eGFP-Naa60 was also detected by
anti-GFP visualized by red secondary antibody in the digitonin-
permeabilized cells (Figure 4, panel 3), thus demonstrating
that the amino end of Naa60 also faces the cytosol. The same
was observed for the N-truncated eGFP-Naa60 variant, eGFP-
Naa60182–242, indicative of amino acid 182’s cytosolic residence.
Figure 3. PROtease Assay for Membrane
Protein Topology, or PROMPT
(A) Principle and constructs of PROMPT. The
protein of interest (POI) is expressed with a
C-terminal double-fluorescent reporter tag com-
posed of eGFP (green) and mCherry (red).
PROMPT determines the membrane topology of
the POI by organelle-specific proteolytic cleavage
of the red fluorescent portion from the PROMPT
construct. The endogenous Golgi-localized pro-
tease, Furin, will find its recognition site (rs) when
the POI C terminus faces the Golgi (left), whereas
the ectopic-expressed VP24 will cleave PROMPT
constructs when the C terminus of the POI is
cytosolic (right). Controls include experiments
performed in the absence of VP24 or with a POI
construct harboring a mutated Furin recognition
site.
(B–D) Validation of PROMPT assay. HeLa S3 (B) or
293 cells (C and D) expressing the indicated con-
structs were fixed and subjected to fluorescence
microscopy (B) or harvested for western blotting
(C and D). Furin-mediated cleavage occurred on
the CD38-construct only in the presence of an
intact Furin recognition site (B and C). The CD4
construct was cleaved not by Furin but by the co-
expressed cytosolic VP24 (B and D).
(E and F) Determination of Naa60’s C-terminal
topology by the PROMPT assay. NAA60 was
subcloned into the PROMPT constructs shown in
(A) and expressed in 293 cells, which were fixed
and subjected to fluorescence microscopy (E) or
western blotting (F). The Naa60 construct was
subject to cleavage not by Furin but by the co-
expressed cytosolic VP24.
Scale bars, 20 mm (B) and 10 mm (E). rs, recognition
site; Mut., mutated; -PROMPT, POI-eGFP-[VP24
rs]-[Furin rs]-mCherry; -PROMPT (F-), POI-eGFP-
[VP24 rs]-[Mut. Furin rs]-mCherry; filled arrow,
intact fusion protein; framed arrow, cleaved fusion
protein.
Furthermore, several antibodies
directed toward specific peptide seq-
uence epitopes of Naa60 were applied
in order to investigate the topology of
various parts of the Naa60 protein. Since
the endogenous Naa60 signal is very
weak, thus representing a challenge in
this assay, we used these antibodies to
detect Naa60-V5 or -FLAG. The three an-
tibodies that successfully recognized
overexpressed Naa60 (anti-Naa603–77,
anti-Naa6069–82, and anti-Naa60192–241;
Figure 4, panels 5–7) were used to deter-
mine the topology of these regions. All these antibodies pro-
duced specific signals in the digitonin-treated samples, thus
determining the cytosolic residency of their respective regions.
Of specific importance is that aa 69–82, which are at the core
of Naa60’s GNAT fold (refer to Figure 2A), were detected on
the cytosolic side of the intracellular membranes. In summary,
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SUPPLEMENTAL DATA 
!
Supplemental Figure legends 
!
Figure!S1.!Additional!co3localization!studies!related!to!Figure!1.!Weak%to%absent%co,localizations%were%
observed%for%tagged%and%endogenous%Naa60%with%various%markers%for%the%secretory%and%endocytic%pathway.!
The!first%column%shows%either%endogenous%or%overexpressed%tagged%Naa60%as%indicated;%the%second%column%
shows%the%subcellular%markers;%and%the%third%column%shows%an%overlay%and%the%rightmost%column%a%zoomed,in%
area%marked%in%the%preceding.%Note%that%there%is%a%difference%the%localization%pattern%of%endogenous%Naa60%
(Naa60),%which%was%more%confined%to%the%Golgi,%and%overexpressed%tagged%Naa60%(Naa60,tGFP),%which%was%
more%widely%distributed%to%other%intracellular%organelles.%The%following%organelle%markers%were%used:%PMP70:%
peroxisomes;%EEA1:%early%endosomes;%LAMP1:%lysosomes;%HSA%(human%serum%albumin):%secretory%vesicles;%
SCG2%(secretogranin%II):%secretory%vesicles;%PDI:%ER.%Scale%bar:%10%µm.!
 
Figure!S2.!Minor!or!no!impact!on!Naa60!membrane!localization!for!the!additional!regions!shown!in!Figure!
2A.!HeLa%cells%expressing%the%indicated%constructs.%
(A)%N,terminal%truncation%(Naa6014,242,tGFP)%and%N,terminal%tagging%(eGFP,Naa60)%interfered%somewhat%with%
the%localization%pattern%of%Naa60.%Note%also%that,%expressing%N,terminally%tagged%Naa60%resulted%in%increased%
appearance%of%enlarged%misshaped%vacuoles.%
(B)%Deletion%of%aa%78,87%putative%loop%(Naa6078,87Δ,tGFP)%did%not%perturb%Naa60%membrane%localization.%
Mutation%(Naa60L220/221A,tGFP)%or%deletion%(Naa60216,221Δ,tGFP)%of%the%QAHSLL%putative%endo/lysosomal%
targeting%signal%did%not%have%any%detectable%effect%on%Naa60%membrane%localization.%
(C)%Naa60%Cys,Ser%mutations%did%not%disrupt%Naa60%membrane%localization.%Several%variants%of%single%and%
multiple%mutations%were%performed.%The%most%extensive%are%shown.%
(D)%2,bromo%palmitate%(2,BP),treatment%did%not%detach%Naa60%from%organelles%but%somewhat%affected%Naa60%
subcellular%distribution,%as%vesicles%appeared%typically%larger%as%well%as%less%abundant%in%the%cell%periphery.%Scale%
bar:%10%µm.%
%
Figure!S3.!COFRADIC3related!validations,!representative!MS!spectra,!in#vitro!peptide!acetylation,!and!
substrate!localization!analysis,!supporting!Table!1.!
(A)%Validation%of%the%subcellular%fractionation%procedure%to%generate%organelle,%and%cytosol,enriched%proteome%
fractions.%A,431%cells%were%subjected%to%crude%subcellular%fractionation%by%means%of%differential%centrifugation.%
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we found all the tested parts of Naa60 to reside at the cytosolic
side of intracellular membranes.
The Organellar Nt-Acetylome: Naa60 Nt-Acetylates
Transmembrane Proteins
Given the unique localization of Naa60, we wondered about
the subcellular localization of its substrates. In order to identify
Figure 4. Naa60 Faces the Cytosol
HeLa cells were subjected to selective membrane
permeabilization immunofluorescence. All probed
regions of Naa60 were mapped to the cytosolic
side: panel 2, C-terminally tagged Naa60-V5 de-
tected with anti-V5; panel 3, N-terminally tagged
eGFP-Naa60 detected with anti-GFP; panel 4,
Naa60 amino acid 182 detected with antibody
toward N-terminal tag on truncated NAA60 (eGFP
Naa60182–242); panel 5, Naa60 aa 3–77 detected
with antibody toward Naa60 peptide sequence 3–
77; panel 6, Naa60 aa 69–82 detected with anti-
body toward Naa60 peptide sequence 69–82; and
panel 7, Naa60 aa 192–241 detected with anti-
body toward Naa60 peptide sequence 192–241.
Lumenal PDI and cytosolic Calnexin controls
(panel 1) were performed in all experiments. In
addition, the PDI control was applied in all cells
where this combination of antibodies and/or fluo-
rophores was compatible. Scale bar, 10 mm.
potential organellar substrates of Naa60,
we performed crude fractionation of
stable isotope labeling by amino acids
in cell culture (SILAC)-labeled NAA60
knockdown and control A-431 cells (Fig-
ures S3A and S3B) and analyzed both
cytosolic and organellar fractions by dif-
ferential N-terminal combined fractional
diagonal chromatography (COFRADIC).
Differential proteome analyses of soluble
and insoluble extracts of control small
interfering RNA (siCTRL)- and siNAA60-
treated cells resulted in the identification
of 1,699 unique N termini, i.e., N-termini
originating from 1,537 unique proteins,
including those of 208 (13%) transmem-
brane proteins (Table S1) and 23 potential
Naa60 substrates (Table 1; Figure S3C).
Interestingly, given the organellar locali-
zation of Naa60, all the substrates were
identified in the organellar fraction and
21 out of the 23 substrates are estab-
lished and/or predicted transmembrane
proteins. Furthermore, among these
transmembrane substrate proteins, there
was a clear overrepresentation of N-in
topology, which corresponds with the
topology of Naa60 established above
(Figures 3 and 4). Of note however, iden-
tified Naa60 substrates covered a variety
of membrane compartments (Table 1;
ER, plasma membrane, Golgi apparatus, mitochondria, and ve-
sicular membranes), even though Naa60 mainly resides at the
Golgi.
Almost all identified Naa60 substrates matched the previously
determined Naa60 substrate specificity (Van Damme et al.,
2011b) and recombinant Naa60-acetylated corresponding pep-
tide sequences in vitro (MVSM and MKQY peptides; Figure S3D),
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Table 1. Naa60 Substrates Identified in the COFRADIC Analysis of Fractionated siCTRL and siNAA60 A-431 Cells
Nt Sequence Start
Nt-Ac
siCTRL (%)
Nt-Ac
siNAA60 (%) D Nt-Ac (%) Protein Full Protein Name Annotated TM (Predicted) TMD
N-Term
Topology
Subcellular
Localizations
MAPKG 1 87 16 71 TRAPga translocon-associated protein subunit gamma O 4 in ER-M
MKQYQ 34 79 25 54 TM222 transmembrane protein 222 O 3 in PM
MGPGPb 1 71 20 51 MFSD12a major facilitator superfamily domain-
containing protein 12
O 9/9+(1) out/in ER-M
MVSMS 1 85 42 43 LAPTM4Aa lysosomal-associated transmembrane
protein 4A
O 4 in ES
MVISE 1 76 38 38 UfSP2a Ufm1-specific protease 2 1 in Cyto, ER
MQGKK 1 66 29 37 OATP3Aa solute carrier organic anion transporter family
member 3A1
O 12/12+(1)/
12+(1)/12+(2)
in PM
MAPKG 1 94 60 34 TM208a transmembrane protein 208 O 2 in ER-M
MLAAKb 26 70 39 31 LAT1 large neutral amino acids transporter small
subunit 1
O 12/12+(1) in C; APM
MLPST 1 100 72 28 UNC50 protein unc-50 homolog O 5 in NIM; GA-M
MAPDP 1 95 69 26 FADS1 Fatty acid desaturase 1 O 3 in ER-M
MKAVQ 148 88 64 24 LRC59 leucine-rich repeat-containing protein 59 O 1 out MI M; ER-M
MVGFG 1 90 68 22 CASC4 protein CASC4 O 1 in M
AAGGSc 2 80 62 18 GSCR2 glioma tumor suppressor candidate region
gene 2 protein
no — NU; NO
MIEES 1 79 62 18 DTN-B dystrobrevin beta (1) out C
AANYS 2 75 58 17 TMM43 transmembrane protein 43 O 3/3+(1) in ER; NIM
MGELP 1 65 49 17 SFXN3 sideroflexin-3 O 4/4+(1) out/in Mito-M
MTQGK 1 96 82 14 HIAT1 hippocampus abundant transcript 1 protein O 11 in M
MYAPG 1 97 85 12 TM127 transmembrane protein 127 O 4 in PM; C
MMGLG 1 95 83 11 GOLM1 Golgi membrane protein 1 O 1 in GA; cis-GA-M
AATALc 2 61 50 11 PTPM1 phosphatidylglycerophosphatase and
protein-tyrosine phosphatase 1
no — MIM
MVSKA 1 14 3 11 UXS1 UDP-glucuronic acid decarboxylase 1 O 1 in GA-M
AAVAA 2 33 22 10 HACD2 very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier
protein] dehydratase 2
O 9/4+(1) in/out ER-M
MAPMG 1 8 0 8 IMP3 inositol monophosphatase 3 O 1/1+(1)/1+(2) in M
See also Table S1 for a complete list of all N termini identified. Abbreviations: DNt-Ac, difference in degree of Nt-acetylation between siCTRL and siNAA60 samples; M, membrane; ES, endo-
membrane system; PM, plasma membrane; C, cytoplasm/cytosol; APM, apical membrane; NIM, nucleus inner membrane; GA, Golgi apparatus; MI, microsome; NU, nucleus; NO, nucleolus;
Mito, mitochondrion; MIM, mitochondrion inner membrane.
aSubstrates used in follow-up studies (Figure S3E).
bN termini whose mass spectrometry spectra are shown in Figure S3C.
cPossibly indirectly affected by NAA60 knockdown.
1
3
6
8
C
e
llR
e
p
o
rts
1
0
,
1
3
6
2
–1
3
7
4
,
M
a
rc
h
3
,
2
0
1
5
ª
2
0
1
5
T
h
e
A
u
th
o
rs
SUPPLEMENTAL DATA 
!
Supplemental Figure legends 
!
Figure!S1.!Additional!co3localization!studies!related!to!Figure!1.!Weak%to%absent%co,localizations%were%
observed%for%tagged%and%endogenous%Naa60%with%various%markers%for%the%secretory%and%endocytic%pathway.!
The!first%column%shows%either%endogenous%or%overexpressed%tagged%Naa60%as%indicated;%the%second%column%
shows%the%subcellular%markers;%and%the%third%column%shows%an%overlay%and%the%rightmost%column%a%zoomed,in%
area%marked%in%the%preceding.%Note%that%there%is%a%difference%the%localization%pattern%of%endogenous%Naa60%
(Naa60),%which%was%more%confined%to%the%Golgi,%and%overexpressed%tagged%Naa60%(Naa60,tGFP),%which%was%
more%widely%distributed%to%other%intracellular%organelles.%The%following%organelle%markers%were%used:%PMP70:%
peroxisomes;%EEA1:%early%endosomes;%LAMP1:%lysosomes;%HSA%(human%serum%albumin):%secretory%vesicles;%
SCG2%(secretogranin%II):%secretory%vesicles;%PDI:%ER.%Scale%bar:%10%µm.!
 
Figure!S2.!Minor!or!no!impact!on!Naa60!membrane!localization!for!the!additional!regions!shown!in!Figure!
2A.!HeLa%cells%expressing%the%indicated%constructs.%
(A)%N,terminal%truncation%(Naa6014,242,tGFP)%and%N,terminal%tagging%(eGFP,Naa60)%interfered%somewhat%with%
the%localization%pattern%of%Naa60.%Note%also%that,%expressing%N,terminally%tagged%Naa60%resulted%in%increased%
appearance%of%enlarged%misshaped%vacuoles.%
(B)%Deletion%of%aa%78,87%putative%loop%(Naa6078,87Δ,tGFP)%did%not%perturb%Naa60%membrane%localization.%
Mutation%(Naa60L220/221A,tGFP)%or%deletion%(Naa60216,221Δ,tGFP)%of%the%QAHSLL%putative%endo/lysosomal%
targeting%signal%did%not%have%any%detectable%effect%on%Naa60%membrane%localization.%
(C)%Naa60%Cys,Ser%mutations%did%not%disrupt%Naa60%membrane%localization.%Several%variants%of%single%and%
multiple%mutations%were%performed.%The%most%extensive%are%shown.%
(D)%2,bromo%palmitate%(2,BP),treatment%did%not%detach%Naa60%from%organelles%but%somewhat%affected%Naa60%
subcellular%distribution,%as%vesicles%appeared%typically%larger%as%well%as%less%abundant%in%the%cell%periphery.%Scale%
bar:%10%µm.%
%
Figure!S3.!COFRADIC3related!validations,!representative!MS!spectra,!in#vitro!peptide!acetylation,!and!
substrate!localization!analysis,!supporting!Table!1.!
(A)%Validation%of%the%subcellular%fractionation%procedure%to%generate%organelle,%and%cytosol,enriched%proteome%
fractions.%A,431%cells%were%subjected%to%crude%subcellular%fractionation%by%means%of%differential%centrifugation.%
Endogenous%Naa60%co,segregated%with%the%organelle%marker%LAMP1%(Pellet%(3×)),%whereas%Naa10%and%Naa30%
were%present%in%the%cytosolic%fraction%(Super%(1×)).%3x%refers%to%3%equivalents%of%lysate%input%to%improve%
immunodetection.%
(B)%Validation%of%samples%prepared%for%COFRADIC.%A,431%cells%grown%in%13C6
15N4%L,arginine,containing%medium%
were%treated%with%non,targeting%control%siRNA%(siCTRL,%,)%and%cells%grown%in%12C6%L,arginine,containing%medium%
were%treated%with%siNAA60%(+).%After%72%hours%cells%were%subjected%to%crude%subcellular%fractionation%as%in%A%
and%subjected%to%COFRADIC%followed%by%LC,MS/MS%analysis.%Sample%aliquots%were%analysed%by%Western%blot.%
(C)%Representative%MS%spectra%of%two%database%annotated%and%initiator%methionine%starting%N,termini%identified%
as%Naa60%substrates%by%N,terminal%COFRADIC.%Upper-panel:%MS%spectrum%of%the%MFSD12%(CS028)%N,terminus%%
(M1GPGP,)%showing%a%ΔNt,Ac%of%51%%between%the%siCTRL%(71%)%and%siNAA60%(20%)%setups.%Lower-panel:%MS%
spectrum%of%the%LAT1%N,terminus%(M1LAAK,)%showing%a%ΔNt,Ac%of%31%%between%the%siCTRL%(70%)%and%siNAA60%
(39%)%setups.%
(D)%NAT%activity%of%recombinant%Naa60%towards%synthetic%oligopeptides.%Purified%recombinant%His,SUMO,Naa60%
was%mixed%with%500%µM%Acetyl%CoA%and%500%µM%of%the%indicated%oligopeptides%in%reaction%buffer%and%incubated%
at%37°C.%Product%formation%was%measured%indirectly%by%adding%DTNB%and%measuring%the%absorbance%at%412%nm.%%
The%NAT%presumed%to%be%responsible%for%the%different%N,terminal%peptide%sequences%in-vivo%is%indicated%below.%
*%indicate%an%N,terminus%previously%determined%as%a%Naa60%substrate%(Van%Damme%et%al.,%2011)%and%#%indicate%
N,termini%identified%as%putative%Naa60%substrates%in%the%present%study%(Table%1),%where%MVSM%and%MKQY%are%
verified%as%substrates%while%AANY%is%not.%(E)%Six%of%the%NatF%substrates%identified%by%means%of%N,terminal%
COFRADIC%(Table%1)%were%tested%for%potential%Nt,acetylation%dependent%effects%on%subcellular%localization.%The%
criteria%for%selecting%these%candidates%were:%i)!at%least%30%%absolute%shift%in%the%degree%of%Nt,acetylation%
between%the%two%setups%analyzed%(8%proteins);%ii)%an%N,terminal%sequence%matching%the%defined%substrate%
specificity%of%Naa60/NatF%(8%proteins);%iii)%a%natural%N,terminus%(starting%with%a%database,annotated%iMet)%(6%
proteins);%iv)%established%or%predicted%as%transmembrane%(6%proteins);%and%v)%an%N,terminus%with%a%predicted%N,
in%topology%(6%proteins).%This%left%TRAPγ%(an%ER,protein%that%constitutes%part%of%the%TRAP,complex%(Hartmann%et%
al.,%1993)),%MFSD12%(a%less%well%studied%protein%whose%related%proteins%localize%to%the%ER%(Angers%et%al.,%2008)),%
LAPTM4A%(localizes%to%endosomes%and%lysosomes%(Hogue%et%al.,%2002)),%UfSP2%(not%experimentally%proven%as%
transmembrane,%but%may%localize%to%the%ER%(Ha%et%al.,%2011)),%OATP3A1%(localizes%to%the%plasma%membrane%
(Kindla%et%al.,%2011)),%and%TM208%(localizes%to%the%ER%(Zhao%et%al.,%2013)).%A,431%cells%were%transfected%with%WT%
or%proline%mutant%versions%(indicated%in%red)%of%C,terminally%tGFP,tagged%substrates%as%indicated.%Scale%bar:%10%
µm.%
%
Figure!S4.!Experiments!supporting!the!specificity!of!Golgi!phenotype!in!NAA60!knockdown!cells!presented!in!
Figure!6.%%
(A)%Left-panel:%CAL,62%cells%immunostained%for%GM130%after%siNAA60%treatment%(smart%pool).%Right-panel:%
quantifications%based%on%cell%counting%from%samples%shown%in%the%left%panel.%Data%are%from%three%individual%
experiments%(n=100,150%cells%per%sample%per%experiment)%for%both%cell%lines.!Error%bars%denote%the%standard%
deviations%of%three%independent%experiments.%siNAA60%significantly%differs%from%siCTRL%in%both%cell%lines%with%
(p<0.05,%ANOVA,%Post%Hoc).%
(B,C)%The%NAA60%knockdown%Golgi%phenotype%was%verified%by%two%alternative%independent%siRNAs,%siNAA60,3%
(30%,%n=292)%and%siNAA60,4%(31%,%n=231)%(B),%as%well%as%an%additional%knockdown%approach%where%NAA60%
shRNA%is%expressed%from%an%RFP,vector,%shNAA60%(shNAA60,89)%vs.%shCTRL%(non,targeting%control%shRNA,15)%
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indicative of the direct action of Naa60 toward these N termini
of transmembrane proteins. Note also that the only two affected
substrates not annotated or predicted to have amembrane span-
ning part (GSCR2 and PTPM1) did not display the canonical
Naa60/NatF substrate specificity (MX-); rather, alanine-alanine
(AA)and two further transmembraneNAA60-knockdown-affected
proteins (TMM43 and HACD2), also corresponded to AA-starting
proteins (Table 1). However, recombinant Naa60 did not signifi-
cantly Nt-acetylate this type of N terminus in vitro (AANY-peptide;
FigureS3D), indicating that these particular N termini are indirectly
affected byNAA60 knockdown rather than being true substrates.
Figure 5. The Naa60/NatF Substrate Cate-
gory Is Enriched for Transmembrane
Proteins
(A) All unique N termini identified in the siCTRL
setup, for which the degree of Nt-acetylation
could be determined, were grouped into trans-
membrane (TM) or non-transmembrane protein N-
termini (no TM) and categorized according their
NAT specificity profile. The ‘‘none’’ category con-
sists of (M)P- starting N termini that are typically
refractory to Nt-acetylation. The color code and
intensity reflects the average percentage of Nt
acetylation as determined in the siCTRL setup;
green and red coloring indicates a degree of Nt
acetylation above and below 50%, respectively.
(B) Venn diagrams of all N termini (left) and all
Naa60/NatF type N termini (right) for which the Nt-
acetylation status could be determined in both the
siCTRL and siNAA60 setups, grouped into trans-
membrane and non-transmembrane proteins.
(C) Bar chart plotting the occurrence of N termini
(i.e.: all Swiss-Prot N termini, all N termini identified
in this study, Naa60 substrate N termini identified
in this study, and Naa30 substrate N termini;
T.V.K., P.V.D., K.K.S., K.G., T.A., V. Jonckheere,
L.M. Myklebust, G. Bjørkøy, and J.E. Varhaug,
unpublished data) for non-transmembrane and
signal-containing proteins, non-transmembrane
proteins without signal sequence, transmembrane
and signal-containing proteins, and transmem-
brane proteins without signal sequence.
To further assess the enrichment of
transmembrane proteins as Naa60 sub-
strates, we first categorized all N termini
identified in the siCTRL setup into trans-
membrane (TM) or non-transmembrane
(no TM) proteins and found that the dis-
tribution of the NAT-substrate classes
differed between the two (Figure 5A).
More specifically, the occurrence of
NatC/F/E-type substrates is increased
in TM proteins at the expense of NatB-
type N termini. It is also noteworthy
that the average degree of Nt-acetyla-
tion is generally reduced among trans-
membrane as compared to non-trans-
membrane proteins (Figure 5A). This
observation is further exemplified by
looking at the differences in Nt-acetylation frequencies be-
tween TM and no TM proteins in sub-categories of NAT-sub-
strate classes, such as (M)T-starting N termini (Table S2). As
such, we here show for the first time at a proteome-wide scale
that Nt-acetylation is a frequent modification among human
transmembrane proteins (occurring on 82% of all identified
TM proteins), although generally to a lower degree as
compared to cytosolic proteins (Figure 5A; Table S2).
Next, identified Naa60 substrates were categorized into
TM and no-TM categories and their distribution related to
all Naa60/NatF-type and all N-termini identified (Figure 5B).
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and C terminus of Naa60 faces the cytosol precludes an odd
number of TMDs. As such, Naa60 could harbor a hairpin helical
structure embedded in the membrane formed by the putative
TMD3 and 4 (refer to Figure 2A), or parts of this region could
be membrane embedded. Most importantly, these topology
data revealed the interesting characterization that even though
Naa60 is an organellar NAT, its activity is directed toward the
cytosol, which was also further corroborated by the known/pre-
dicted N-out topologies of the Naa60 substrates identified.
Our data on Naa60 targeting and topology contrast that
described by Yang and colleagues (Yang et al., 2011), who
Figure 6. NAA60 Knockdown Affects Golgi
Morphology
(A) Abnormal Golgi morphology was observed in
siNAA60-treated, but not siNAA50-treated, HeLa
cells immunostained for the cis-Golgi marker
GM130 and compared to siCTRL. Images are
based on cell counts showing fragmented Golgi in
14% of siCTRL (n = 338), 14% of siNAA50 (n =
263), and 38% of siNAA60 (n = 231). See also
Figure S4A for additional statistics.
(B) Reduction in mRNA level after treatment of
HeLa cells with smart pool siRNA used in (A).
NAA50,NAA60, and ACTIN PCRswere performed
on cDNA synthesized from RNA isolates from cells
treated with siCTRL, siNAA50 and siNAA60 cells
as in (A). This confirmation was performed in all
siRNA experiments.
(C) Left: the siNAA60-induced Golgi phenotype
could be rescued by Naa60-V5 expression, but
not by expressing any of the cytosolic NATs
(Naa10-, Naa30-, or Naa50-V5). Cells were treated
with siNAA60-4 and, 3–4 hr later, transfected with
V5 plasmids encoding the indicated proteins.
Naa60-V5 contained silent mutations enabling
expression in siNAA60-4-treated cells. The % of
cells displaying a fragmented Golgi was counted
among V5-positive cells only, except in the siCTRL
and the siNAA60-4 samples (bars 1 and 2). Addi-
tionally, to exclude plasmid expression efficacies
as a confounding variable, an expression control
(Naa60-low expr.) was performed where the ‘‘si-
NAA60-4 + Naa60-V5’’ condition was recounted,
only considering the weakest half of the V5-posi-
tive cell population. Right: immunofluorescence
images from the same experiment as to the left.
(D) siCTRL- and siNAA60-treated cells co-immu-
nostained for GM130 and Mannosidase II (ManII)
revealed that these cis- andmedial-Golgi markers
cohered equally well in control and Golgi pheno-
typic cells. Three differing degrees of Golgi struc-
tural effects observed in the siNAA60 cells are
shown.
All scale bars represent 10 mm. See also validating
data in Figure S4 and additional data in Figure S5.
claimed that deletion of putative TMD1
and TMD2 (termed A and B in their
work) leaves a cytosolic Naa60 (termed
HAT4 in their work). We disagree with
the interpretation of these results. The
C-terminal truncated Naa60, used in our
study, shows a complete loss of the organellar localization and
is supported by the capacity of this C-terminal Naa60 region
(aa 182–242) to target eGFP to the same localization. In the
work of Yang et al., the deleted part (aa 52–103), claimed to be
transmembrane, covered a large portion of the catalytic GNAT
domain, and this is not discussed. Furthermore, we have here
established that aa 69–82, a crucial part of the GNAT domain,
faces the cytosolic side. Importantly, our finding that Naa60
Nt-acetylates cytosolic N termini of transmembrane proteins
also robustly supports the cytosolic position of the GNAT
domain.
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(D) siCTRL- and siNAA60-treated cells co-immu-
nostained for GM130 and Mannosidase II (ManII)
revealed that these cis- andmedial-Golgi markers
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tural effects observed in the siNAA60 cells are
shown.
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claimed that deletion of putative TMD1
and TMD2 (termed A and B in their
work) leaves a cytosolic Naa60 (termed
HAT4 in their work). We disagree with
the interpretation of these results. The
C-terminal truncated Naa60, used in our
study, shows a complete loss of the organellar localization and
is supported by the capacity of this C-terminal Naa60 region
(aa 182–242) to target eGFP to the same localization. In the
work of Yang et al., the deleted part (aa 52–103), claimed to be
transmembrane, covered a large portion of the catalytic GNAT
domain, and this is not discussed. Furthermore, we have here
established that aa 69–82, a crucial part of the GNAT domain,
faces the cytosolic side. Importantly, our finding that Naa60
Nt-acetylates cytosolic N termini of transmembrane proteins
also robustly supports the cytosolic position of the GNAT
domain.
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were%treated%with%siNAA60%(+).%After%72%hours%cells%were%subjected%to%crude%subcellular%fractionation%as%in%A%
and%subjected%to%COFRADIC%followed%by%LC,MS/MS%analysis.%Sample%aliquots%were%analysed%by%Western%blot.%
(C)%Representative%MS%spectra%of%two%database%annotated%and%initiator%methionine%starting%N,termini%identified%
as%Naa60%substrates%by%N,terminal%COFRADIC.%Upper-panel:%MS%spectrum%of%the%MFSD12%(CS028)%N,terminus%%
(M1GPGP,)%showing%a%ΔNt,Ac%of%51%%between%the%siCTRL%(71%)%and%siNAA60%(20%)%setups.%Lower-panel:%MS%
spectrum%of%the%LAT1%N,terminus%(M1LAAK,)%showing%a%ΔNt,Ac%of%31%%between%the%siCTRL%(70%)%and%siNAA60%
(39%)%setups.%
(D)%NAT%activity%of%recombinant%Naa60%towards%synthetic%oligopeptides.%Purified%recombinant%His,SUMO,Naa60%
was%mixed%with%500%µM%Acetyl%CoA%and%500%µM%of%the%indicated%oligopeptides%in%reaction%buffer%and%incubated%
at%37°C.%Product%formation%was%measured%indirectly%by%adding%DTNB%and%measuring%the%absorbance%at%412%nm.%%
The%NAT%presumed%to%be%responsible%for%the%different%N,terminal%peptide%sequences%in-vivo%is%indicated%below.%
*%indicate%an%N,terminus%previously%determined%as%a%Naa60%substrate%(Van%Damme%et%al.,%2011)%and%#%indicate%
N,termini%identified%as%putative%Naa60%substrates%in%the%present%study%(Table%1),%where%MVSM%and%MKQY%are%
verified%as%substrates%while%AANY%is%not.%(E)%Six%of%the%NatF%substrates%identified%by%means%of%N,terminal%
COFRADIC%(Table%1)%were%tested%for%potential%Nt,acetylation%dependent%effects%on%subcellular%localization.%The%
criteria%for%selecting%these%candidates%were:%i)!at%least%30%%absolute%shift%in%the%degree%of%Nt,acetylation%
between%the%two%setups%analyzed%(8%proteins);%ii)%an%N,terminal%sequence%matching%the%defined%substrate%
specificity%of%Naa60/NatF%(8%proteins);%iii)%a%natural%N,terminus%(starting%with%a%database,annotated%iMet)%(6%
proteins);%iv)%established%or%predicted%as%transmembrane%(6%proteins);%and%v)%an%N,terminus%with%a%predicted%N,
in%topology%(6%proteins).%This%left%TRAPγ%(an%ER,protein%that%constitutes%part%of%the%TRAP,complex%(Hartmann%et%
al.,%1993)),%MFSD12%(a%less%well%studied%protein%whose%related%proteins%localize%to%the%ER%(Angers%et%al.,%2008)),%
LAPTM4A%(localizes%to%endosomes%and%lysosomes%(Hogue%et%al.,%2002)),%UfSP2%(not%experimentally%proven%as%
transmembrane,%but%may%localize%to%the%ER%(Ha%et%al.,%2011)),%OATP3A1%(localizes%to%the%plasma%membrane%
(Kindla%et%al.,%2011)),%and%TM208%(localizes%to%the%ER%(Zhao%et%al.,%2013)).%A,431%cells%were%transfected%with%WT%
or%proline%mutant%versions%(indicated%in%red)%of%C,terminally%tGFP,tagged%substrates%as%indicated.%Scale%bar:%10%
µm.%
%
Figure!S4.!Experiments!supporting!the!specificity!of!Golgi!phenotype!in!NAA60!knockdown!cells!presented!in!
Figure!6.%%
(A)%Left-panel:%CAL,62%cells%immunostained%for%GM130%after%siNAA60%treatment%(smart%pool).%Right-panel:%
quantifications%based%on%cell%counting%from%samples%shown%in%the%left%panel.%Data%are%from%three%individual%
experiments%(n=100,150%cells%per%sample%per%experiment)%for%both%cell%lines.!Error%bars%denote%the%standard%
deviations%of%three%independent%experiments.%siNAA60%significantly%differs%from%siCTRL%in%both%cell%lines%with%
(p<0.05,%ANOVA,%Post%Hoc).%
(B,C)%The%NAA60%knockdown%Golgi%phenotype%was%verified%by%two%alternative%independent%siRNAs,%siNAA60,3%
(30%,%n=292)%and%siNAA60,4%(31%,%n=231)%(B),%as%well%as%an%additional%knockdown%approach%where%NAA60%
shRNA%is%expressed%from%an%RFP,vector,%shNAA60%(shNAA60,89)%vs.%shCTRL%(non,targeting%control%shRNA,15)%
(C).%In%shRNA,positive%cells,%the%fragmented%Golgi%phenotype%was%observed%in%16%%of%shCTRL,15%(n=161)%and%
52%%of%shNAA60,89%(n=185)%amongst%the%RFP,positive%cells.%Scale%bars:%10%µm%(A,%C);%5%µm%(B).%
%
Figure!S5.!NAA60!knockdown!did!not!cause!cytoskeletal!disassembly!or!structural!perturbation!of!organelles!
other!than!the!Golgi!fragmentation!shown!in!Figure!6.!
(A)%The%Golgi,localized%Giantin%was%shown%to%display%the%same%phenotype%as%GM130,%thus%verifying%Giantin%as%a%
marker%for%knockdown%cells%similarly%as%GM130.%
(B)%The%siNAA60,induced%structural%effect%was%specific%to%the%Golgi%and%no%alterations%were%observed%for%other%
organelles%or%for%the%F,actin%or%microtubule%cytoskeleton.%PDI:%ER,marker;%COX%IV:%mitochondrial%marker;%
PMP70:%peroxisome%marker;%EEA1:%endosomal%marker;%LAMP1:%lysosomal%marker;%Rhodamine%Phalloidin:%actin%
cytoskeleton%stain;%and%β,tubulin:%microtubule%cytoskeleton.%Giantin%was%used%as%a%Golgi%marker%when%
combined%with%rabbit%antibody%against%EEA1.%In%all%other%panels%mouse,derived%antibodies%were%used%and%
GM130%was%used%as%Golgi%marker.%Scale%bar:%10µm.%
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Figure!6.%%
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organelles%or%for%the%F,actin%or%microtubule%cytoskeleton.%PDI:%ER,marker;%COX%IV:%mitochondrial%marker;%
PMP70:%peroxisome%marker;%EEA1:%endosomal%marker;%LAMP1:%lysosomal%marker;%Rhodamine%Phalloidin:%actin%
cytoskeleton%stain;%and%β,tubulin:%microtubule%cytoskeleton.%Giantin%was%used%as%a%Golgi%marker%when%
combined%with%rabbit%antibody%against%EEA1.%In%all%other%panels%mouse,derived%antibodies%were%used%and%
GM130%was%used%as%Golgi%marker.%Scale%bar:%10µm.%
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Table!S1.!List!of!1,699!unique!human!N3terminal!peptides!identified,!related!to!Table!1!
List%of%1,699%human%N,termini%identified%in%the%cytoplasmic%and%organellar,enriched%proteome%fractions%of%
siCTRL-and%siNAA60,treated%human%A,431%cells.%Swiss,Prot%accession,%identified%peptide%sequence,%start%and%
end%positions,%and%experiment%number(s)%in%which%the%peptide%was%identified%(1%and%2%indicate%cytoplasmic%and%
organelle,enriched%fractions,%respectively)%are%shown.%NatF%substrate,%amino%acid%residue%preceding%the%
identified%N,terminus%(P1;%if%any),%N,terminal%modification%status/states%confirmed%by%tandem%mass%
spectrometry%(MS/MS)%(per%setup),%degree%(%)%of%Nt,acetylation%(per%setup/difference%between%setups/in%
total),%number%of%identified%spectra%(per%setup/in%total),%and%global%Nt,modification%status%in%the%siCTRL%setup(s)%
(N,termini%found%to%be%less%than%2%%Nt,Ac%and%more%than%98%%Nt,Ac)%were%considered%as%100%%free%and%100%%
Nt,Ac,%respectively,%when%considering%their%global%Nt,Ac%status.%N.D.%(not%determined)%indicates%N,termini%
where%acetylation%status%could%not%be%calculated.%UniProt%database%primary%accession%number,%protein%
description,%gene%symbols,%protein%length%(aa),%Gene%Ontology%terms,%subcellular%localizations,%and,%whenever%a%
peptide%matched%to%multiple%members%of%a%protein%family%(redundancy)%isoforms%are%given%for%all%uniquely%
identified%yeast%N,termini.%Maximum%Mascot%ion%score,%delta%threshold%(=%maximum%score%−%minimum%
threshold),%minimum%threshold%score,%confidence%level%of%identification,%and%C,terminal%modification%
status/states%confirmed%by%MS/MS%(in%total)%are%also%indicated.%N,termini%are%ranked%alphabetically.%
!(Table%uploaded%as%a%separate%Excel%file)%
!
! !
Table!S2.!Nt3acetylation!status!of!transmembrane!versus!non3transmembrane!protein!N3termini,!related!to!Table!1!and!S1!
and!Figure!5.%
Transmembrane!
!
!
Non3transmembrane!
NAT!a!
Start!
with!
Met!
Amino!
1!
Nt3Ac!
NAT!
Start!
with!
Met!
Amino!
1!
Nt3Ac!
Free! Full! Partial! Total! Free! Full! Partial! Total!
NatA% 0% A% 9% % 70!%! 21!%! 91% % NatA% 0% A% 3% % 92!%! 5!%! 97% %
C% 0% % 100% % 0% % 100% % C% 50% % 50% % 0% % 50% %
G% 80% % 0% % 20% % 20% % G% 52% % 22% % 26% % 48% %
S% 4% % 87% % 9!%! 96% % S% 1% % 99% % 1% % 99% %
T% 60!%! 20!%! 20% % 40% % T% 10!%! 73!%! 18% % 90% %
V% 83% % 0% % 17% % 17% % V% 79% % 3% % 17% % 21% %
NatB% 1% D% 0% % 100% % 0% % 100% % NatB% 1% D% 0% % 99% % 1% % 100% %
E% 0% % 86!%! 14!%! 100% % E% 0% % 99!%! 0!%! 100% %
N% 0% % 57!%! 43!%! 100% % N% 0% % 96!%! 4!%! 100% %
Q% 50% % 0% % 50% % 50% % Q% 0% % 80% % 20% % 100% %
NatC% 1% I% 0% % 100% % 0% % 100% % NatC% 1% F% 29% % 57% % 14% % 71% %
L% 20% % 40% % 40% % 80% % I% 29% % 29% % 43% % 71% %
Other% 0% F% 0% % 100% % 0% % 100% % L% 7% % 62% % 31% % 93% %
N% 0% % 100% % 0% % 100% % Other% 0% D% 0% % 100% % 0% % 100% %
P% 86% % 0% % 14% % 14% % E% 0% % 100% % 0% % 100% %
1% A% 14% % 14% % 71!%! 86% % F% 0% % 100% % 0% % 100% %
G% 0% % 0% % 100% % 100% % I% 100% % 0% % 0% % 0% %
K% 57!%! 0!%! 43!%! 43% % K% 100% % 0% % 0% % 0% %
M% 0% % 0% % 100% % 100% % N% 0% % 100% % 0% % 100% %
T% 33% % 33% % 33% % 67% % P% 96% % 4% % 0% % 4% %
V% 27% % 18% % 55% % 73% % 1% A% 0% % 100% % 0!%! 100% %
Y% 50% % 0% % 50% % 50% % G% 0% % 20% % 80% % 100% %
% % % - %
H% 0% % 100% % 0% % 100% %
K% 34!%! 11!%! 55!%! 66% %
M% 0% % 80% % 20% % 100% %
P% 100% % 0% % 0% % 0% %
S% 17% % 33% % 50% % 83% %
T% 0% % 84% % 16% % 100% %
V% 15% % 35% % 50% % 85% %
Y% 0% % 100% % 0% % 100% %
Grand!Total! 18!%! 58!%! 24!%! 82!%! Grand!Total! 10!%! 82!%! 8!%! 90!%!
a!N,termini%are%categorized%according%to%their%NAT%substrate%class.%Bold%numbers%indicate%categories%with%notable%differences%
in%Nt,acetylation%levels%between%transmembrane%and%non,transmembrane%proteins.%(See%also%Table%S1%for%a%complete%list%of%
all%N,termini%identified).%%
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